 Melissa New
Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchoscopy | 2 | 2025 | 223 | 1.690 |
Why?
| | Lung Neoplasms | 9 | 2025 | 2526 | 1.250 |
Why?
| | Hemoptysis | 2 | 2023 | 36 | 1.040 |
Why?
| | Anatomy | 1 | 2024 | 27 | 0.890 |
Why?
| | Virtual Reality | 1 | 2024 | 61 | 0.840 |
Why?
| | Endosonography | 1 | 2024 | 156 | 0.820 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2023 | 22 | 0.810 |
Why?
| | Epoprostenol | 3 | 2018 | 136 | 0.800 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2023 | 23 | 0.800 |
Why?
| | Simulation Training | 1 | 2023 | 106 | 0.730 |
Why?
| | Education, Medical | 1 | 2023 | 266 | 0.660 |
Why?
| | Biomarkers, Tumor | 1 | 2025 | 1276 | 0.560 |
Why?
| | Anticarcinogenic Agents | 1 | 2018 | 77 | 0.560 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 209 | 0.510 |
Why?
| | Physicians | 1 | 2023 | 910 | 0.450 |
Why?
| | Clinical Competence | 3 | 2024 | 1118 | 0.370 |
Why?
| | Early Detection of Cancer | 3 | 2021 | 447 | 0.350 |
Why?
| | Neoplasms, Experimental | 2 | 2018 | 176 | 0.270 |
Why?
| | Smoke | 2 | 2018 | 141 | 0.250 |
Why?
| | Telerehabilitation | 1 | 2023 | 37 | 0.200 |
Why?
| | Cross-Over Studies | 1 | 2024 | 564 | 0.190 |
Why?
| | Equipment Design | 1 | 2023 | 522 | 0.180 |
Why?
| | Iloprost | 2 | 2018 | 45 | 0.180 |
Why?
| | Carcinogens | 2 | 2018 | 125 | 0.170 |
Why?
| | Bronchi | 2 | 2018 | 260 | 0.160 |
Why?
| | Computer Simulation | 1 | 2023 | 978 | 0.150 |
Why?
| | Humans | 12 | 2025 | 137585 | 0.150 |
Why?
| | Tobacco Smoking | 1 | 2018 | 25 | 0.150 |
Why?
| | Cancer Survivors | 1 | 2023 | 285 | 0.150 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2018 | 68 | 0.150 |
Why?
| | Mice, Transgenic | 3 | 2018 | 2167 | 0.150 |
Why?
| | Reminder Systems | 1 | 2019 | 169 | 0.140 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2018 | 155 | 0.140 |
Why?
| | Curriculum | 1 | 2023 | 992 | 0.130 |
Why?
| | Frizzled Receptors | 1 | 2016 | 25 | 0.130 |
Why?
| | Models, Statistical | 1 | 2020 | 669 | 0.120 |
Why?
| | Patient Compliance | 1 | 2019 | 581 | 0.120 |
Why?
| | Epithelial Cells | 2 | 2018 | 1096 | 0.110 |
Why?
| | Internship and Residency | 1 | 2024 | 1147 | 0.110 |
Why?
| | Telemedicine | 1 | 2023 | 862 | 0.110 |
Why?
| | Health Personnel | 1 | 2020 | 710 | 0.100 |
Why?
| | Antihypertensive Agents | 1 | 2017 | 494 | 0.100 |
Why?
| | Cell Line | 1 | 2018 | 2847 | 0.100 |
Why?
| | Cohort Studies | 1 | 2023 | 5742 | 0.100 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1587 | 0.090 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2020 | 1329 | 0.090 |
Why?
| | Surveys and Questionnaires | 1 | 2023 | 5778 | 0.090 |
Why?
| | Prospective Studies | 1 | 2023 | 7604 | 0.080 |
Why?
| | Adenocarcinoma | 1 | 2017 | 940 | 0.080 |
Why?
| | MicroRNAs | 1 | 2016 | 692 | 0.080 |
Why?
| | Risk Factors | 1 | 2023 | 10388 | 0.070 |
Why?
| | Urethane | 2 | 2017 | 43 | 0.070 |
Why?
| | Biomarkers | 1 | 2018 | 4149 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2607 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2018 | 10811 | 0.060 |
Why?
| | Mice | 3 | 2018 | 17787 | 0.060 |
Why?
| | Female | 4 | 2024 | 73304 | 0.050 |
Why?
| | Male | 3 | 2024 | 67762 | 0.050 |
Why?
| | Animals | 3 | 2018 | 36940 | 0.040 |
Why?
| | Receptors, Prostaglandin | 1 | 2017 | 22 | 0.030 |
Why?
| | Lung | 2 | 2023 | 4060 | 0.030 |
Why?
| | Biological Availability | 1 | 2017 | 148 | 0.030 |
Why?
| | Receptors, CXCR4 | 1 | 2017 | 86 | 0.030 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2017 | 184 | 0.030 |
Why?
| | Medicaid | 1 | 2021 | 435 | 0.030 |
Why?
| | Aged | 3 | 2021 | 23961 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 773 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2020 | 786 | 0.030 |
Why?
| | Middle Aged | 3 | 2021 | 33479 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2021 | 15657 | 0.020 |
Why?
| | Smoking | 1 | 2019 | 1627 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4030 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5131 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2017 | 2475 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3412 | 0.020 |
Why?
| | Colorado | 1 | 2019 | 4565 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2691 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2016 | 4193 | 0.020 |
Why?
| | United States | 1 | 2021 | 14841 | 0.010 |
Why?
|
|
New's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|